Neu differentiation factor (NDF, also called neuregulin) is a potent inducer of epithelial cell proliferation and has been shown to induce mammary carcinomas in transgenic mice. Notwithstanding this proliferative effect, we have shown that a novel isoform of NDF can induce apoptosis when overexpressed. Here we report that this property also extends to other NDF isoforms and that the cytoplasmic portion of NDF is largely responsible for the apoptotic effect, whereas the proliferative activity is likely to depend upon the secreted version of NDF. In accordance with these contradictory properties, we find that tumors induced by NDF display extensive apoptosis in vivo. NDF is therefore an oncogene whose deregulation can induce transformation as well as apoptosis.
Neu Differentiation Factor (NDF), a Dominant Oncogene, Causes Apoptosis In Vitro and In Vivo
Address correspondence to Philip Leder, Department of Genetics, Harvard Medical School and Howard Hughes Medical Institute, 200 Longwood Ave., Boston, MA 02115. Phone: 617-432-7662; Fax: 617-432-7944; E-mail: [email protected]
S. Grimm was supported by the AIDS Stipendium of the Deutsche Krebsforschungszentrum, Heidelberg, Germany, and by a grant from the Howard Hughes Medical Institute.
Stefan Grimm's present address is Max-Planck Institute for Biochemistry, Martinsried, Germany.
Ian M. Krane's present address is Genzyme Transgenics Inc., Framingham, MA.
Stefan Grimm, Edward J. Weinstein, Ian M. Krane, Philip Leder; Neu Differentiation Factor (NDF), a Dominant Oncogene, Causes Apoptosis In Vitro and In Vivo . J Exp Med 19 October 1998; 188 (8): 1535–1539. doi: https://doi.org/10.1084/jem.188.8.1535
Download citation file:
Sign in
Client Account
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement